Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Catherine Mace, Lausanne CH

Catherine Mace, Lausanne CH

Patent application numberDescriptionPublished
20100233303PREVENTION AND TREATMENT OF DISORDERS CONNECTED TO IMPAIRED NEUROTRANSMISSION - The present invention relates to the use of rosemary extracts for the prevention and treatment of disorders connected to impaired neurotransmission such as depression in humans, companion animals and farm animals09-16-2010
20110002900MEDIUM CHAIN DICARBOXYLIC ACIDS, THEIR DERIVATES AND METABOLIC DISORDERS - The present invention relates in general to medium chain dicarboxylic acids, their derivatives and their uses. In particular, the present invention relates to a composition comprising medium chain dicarboxylic acids and to the use of medium chain dicarboxylic acids and their derivatives for the preparation of products to treat or prevent metabolic disorders. The composition of the present invention can particularly well be used to treat or prevent hyperglycemia, for example diabetes.01-06-2011
20110123501GUT FLORA AND WEIGHT MANAGEMENT - The present invention relates to supporting weight management, weight loss and/or to the prevention and/or treatment of metabolic disorders. In particular the present invention relates to preventing and/or treating metabolic disorders by modulating, in particular reducing the amount of proteobacteria and/or deferribacteres in the gut. One embodiment of the present invention relates to the use of a primary composition comprising an agent that reduces the amount of proteobacteria, preferably gamma-proteobacteria, even more preferred enterobacteria; and/or deferribacteres in the gut for the preparation of a composition to treat or prevent metabolic disorders, to support weight loss and/or to support weight management.05-26-2011
20110244072MODULATION OF INFANT FAT MASS - A method of reducing the accumulation of fat mass in a neonatal human infant at risk thereof which method comprises administering to the infant during at least a part of the neonatal period a therapeutic amount of a nutritional composition comprising proteins in an amount such that the composition contains more than 2.4 g of protein per 100 kcal. As weight gain during the first week of life has been associated with overweight in adulthood, this may offer a method of reducing the risk of developing obesity in later life. Also claimed is the administration of DHA to the mother during gestation period.10-06-2011
20110293568LACTOBACILLUS HELVETICUS CNCM I-4095 AND WEIGHT CONTROL - The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of 12-01-2011
20110293569LACTOBACILLUS RHAMNOSUS CNCM I-4096 AND WEIGHT CONTROL - The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of 12-01-2011
20120004163NUTRITIONAL COMPOSITION FOR INFANTS - A nutritional composition for infants comprises a protein source, a lipid source and a carbohydrate source wherein the lipid source includes at least 16 wt % linoleic acid and at least 2 wt % α-linolenic acid expressed as a percentage of total fatty acid content in each case and in amounts such that the ratio of linoleic acid:α-linolenic acid is in the range from 1 to 10.01-05-2012
20120021977PROMOTION OF HEALTHY CATCH-UP GROWTH - The use of a protein source comprising bovine casein proteins for the preparation of a nutrional composition for administration to an infant, young child or adult during or after a period of catch-up growth or weight recovery, following a period of growth restriction or weight lost, so as improve growth at early age and/or to reduce the risk of development of insulin resistance and/or Type 2 diabetes later in the life of the infant, young child or adult.01-26-2012

Patent applications by Catherine Mace, Lausanne CH